Last update 15 Oct 2025

Plosaracetam

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ABBV552, SDI 118, SDI-118
Target
Action
modulators
Mechanism
SV2A modulators(Synaptic vesicle glycoprotein 2A modulators)
Therapeutic Areas
Active Indication
Originator Organization
Active Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC13H10ClF3N4O
InChIKeyGPGBFZCJDZALPN-QMMMGPOBSA-N
CAS Registry1651179-19-9

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alzheimer DiseasePhase 2
United States
05 Jun 2023
Alzheimer DiseasePhase 2
Japan
05 Jun 2023
Alzheimer DiseasePhase 2
Australia
05 Jun 2023
Alzheimer DiseasePhase 2
Germany
05 Jun 2023
Alzheimer DiseasePhase 2
New Zealand
05 Jun 2023
Alzheimer DiseasePhase 2
Spain
05 Jun 2023
Alzheimer DiseasePhase 2
United Kingdom
05 Jun 2023
Cognitive DysfunctionPhase 1
Germany
23 Sep 2021
Cognitive DysfunctionPhase 1
United Kingdom
23 Sep 2021
Depressive DisorderPhase 1
United Kingdom
16 Sep 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
263
Placebo for ABBV-552
(Placebo)
qydbprvsfo(iosjrjjmji) = exkjkuolxv cclebbqequ (lymixctewt, 0.660)
-
15 Oct 2025
(ABBV-552: 1 mg)
qydbprvsfo(iosjrjjmji) = wawnlutmij cclebbqequ (lymixctewt, 0.668)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free